Co-Authors
This is a "connection" page, showing publications co-authored by Michael Machiorlatti and Sara Vesely.
Connection Strength
0.470
-
Disparity in outcomes of melanoma adjuvant immunotherapy by demographic profile. Melanoma Manag. 2020 Jul 16; 7(2):MMT43.
Score: 0.182
-
Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy. Future Sci OA. 2020 Jun 25; 6(7):FSO581.
Score: 0.045
-
Predictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer Database. Anticancer Res. 2020 Feb; 40(2):847-855.
Score: 0.044
-
Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database. Oncologist. 2020 02; 25(2):e276-e283.
Score: 0.043
-
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. 2019 01; 25(1):141-151.
Score: 0.041
-
Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors: A Cost Analysis Study. Am J Ther. 2018 Nov/Dec; 25(6):e767-e768.
Score: 0.040
-
Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution's 12-year Experience. Anticancer Res. 2017 09; 37(9):5019-5025.
Score: 0.037
-
Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2017 07; 17(7):450-456.e2.
Score: 0.037